, Schliephake D, Pannier F. Efficacy and safety of great
saphenous vein sclerotherapy using standardised polidocanol foam
(ESAF): a randomised controlled multicentre clinical trial. Eur J Vasc
Endovasc Surg 2008;35:238-45.
332. Yamaki T, Nozaki M, Iwasaka S. Comparative study of duplex-guided
foam sclerotherapy and duplex-guided liquid sclerotherapy for the
treatment of superficial venous insufficiency. Dermatol Surg 2004;30:
718-22.
333. Cabrera J, Cabrera J Jr, Garcia-Olmedo MA. Sclerosants in microfoam: a new approach in angiology. Int Angiol 2001;20:322-9.
334. Darvall KA, Sam RC, Bate GR, Silverman SH, Adam DJ, Bradbury
AW, et al. Changes in health-related quality of life after ultrasoundguided foam sclerotherapy for great and small saphenous varicose
veins. J Vasc Surg 2010;51:913-20.
335. Rigby KA, Palfreyman SJ, Beverley C, Michaels JA. Surgery versus
sclerotherapy for the treatment of varicose veins. Cochrane Database
Syst Rev 2004:CD004980.
336. Perrin M. Endovenous radiofrequency ablation of saphenous vein
reflux. The VNUS Closure procedure with Closurefast. An updated
review. Int Angiol 2010;29:303-7.
337. Enzler MA, van den Bos RR. A new gold standard for varicose vein
treatment? Eur J Vasc Endovasc Surg 2010;39:97-8.
338. Gay J. On varicose disease of the lower extremities and its allied
disorders: skin discoloration, induration, and ulcer: being the Lettsomian Lectures delivered before the Medical Society of London in
186